Similar articles for PMID: 15144854

Year	Number of Results
1981	1
1994	1
1997	3
1998	23
1999	22
2000	24
2001	23
2002	31
2003	47
2004	55
2005	34
2006	13
2007	10
2008	8
2009	9
2010	19
2011	19
2012	13
2013	17
2014	17
2015	20
2016	27
2017	19
2018	28
2019	14
2020	15
2021	19
2022	17
2023	9
2024	0

1

Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.

Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, Lee VM. Kotzbauer PT, et al. Exp Neurol. 2004 Jun;187(2):279-88. doi: 10.1016/j.expneurol.2004.01.007. Exp Neurol. 2004. PMID: 15144854

2

Initiation and synergistic fibrillization of tau and alpha-synuclein.

Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ, Lee VM. Giasson BI, et al. Science. 2003 Apr 25;300(5619):636-40. doi: 10.1126/science.1082324. Science. 2003. PMID: 12714745

3

Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.

Jo E, Fuller N, Rand RP, St George-Hyslop P, Fraser PE. Jo E, et al. J Mol Biol. 2002 Jan 25;315(4):799-807. doi: 10.1006/jmbi.2001.5269. J Mol Biol. 2002. PMID: 11812148

4

Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease.

Kumar S, Sarkar A, Sundar D. Kumar S, et al. Biochem Biophys Res Commun. 2009 Sep 18;387(2):305-9. doi: 10.1016/j.bbrc.2009.07.008. Epub 2009 Jul 4. Biochem Biophys Res Commun. 2009. PMID: 19580781

5

From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.

Goedert M, Spillantini MG, Serpell LC, Berriman J, Smith MJ, Jakes R, Crowther RA. Goedert M, et al. Philos Trans R Soc Lond B Biol Sci. 2001 Feb 28;356(1406):213-27. doi: 10.1098/rstb.2000.0767. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11260802 Free PMC article. Review.

6

Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.

Mishizen-Eberz AJ, Norris EH, Giasson BI, Hodara R, Ischiropoulos H, Lee VM, Trojanowski JQ, Lynch DR. Mishizen-Eberz AJ, et al. Biochemistry. 2005 May 31;44(21):7818-29. doi: 10.1021/bi047846q. Biochemistry. 2005. PMID: 15909996

7

Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Goedert M. Goedert M. Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1101-18. doi: 10.1098/rstb.1999.0466. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434313 Free PMC article. Review.

8

A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein.

Du HN, Tang L, Luo XY, Li HT, Hu J, Zhou JW, Hu HY. Du HN, et al. Biochemistry. 2003 Jul 29;42(29):8870-8. doi: 10.1021/bi034028+. Biochemistry. 2003. PMID: 12873148

9

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

Conway KA, Harper JD, Lansbury PT. Conway KA, et al. Nat Med. 1998 Nov;4(11):1318-20. doi: 10.1038/3311. Nat Med. 1998. PMID: 9809558

10

Following the leader: fibrillization of alpha-synuclein and tau.

Frasier M, Wolozin B. Frasier M, et al. Exp Neurol. 2004 Jun;187(2):235-9. doi: 10.1016/j.expneurol.2004.02.008. Exp Neurol. 2004. PMID: 15144849 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

520 results

Results by year